Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid β-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy

FEBS Letters

Volumn 579, Issue 2, 2005, Pages 409-414

  Morita, Masashi ^a   Takahashi, Ikuko ^a   Kanai, Mariko ^a   Okafuji, Fumito ^a   Iwashima, Makoto ^a   Hayashi, Toshimitsu ^a   Watanabe, Shiro ^a   Hamazaki, Tomohito ^a   Shimozawa, Nobuyuki ^b   Suzuki, Yasuyuki ^c   Furuya, Hirokazu ^d   Yamada, Takeshi ^d   Imanaka, Tsuneo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Adrenoleukodystrophy; ATP binding cassette protein; Baicalein; Flavonoid; Peroxisome; Very long chain fatty acid

Indexed keywords

AMENTOFLAVONE; APIGENIN; ASTILBIN; BAICALEIN; BAICALEIN 5,6,7 TRIMETHYL ETHER; CHOLESTEROL ESTER; DIOSMETIN; ERIODICTYOL; FLAVANOID; FORMONONETIN; GENISTEIN; HESPERIDIN; HYPERIN; ISOQUERCITRIN; KAEMPFEROL; LIGNOCERIC ACID; LINARIN; LIQUIRITIN; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; MYRICETIN; ORIENTIN; QUERCETIN; RUTOSIDE; SCUTELLAREIN; TAXIFOLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LONG CHAIN FATTY ACID; VITEXIN; WOGONIN;

ADRENOLEUKODYSTROPHY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SCREENING; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADRENOLEUKODYSTROPHY; CELLS, CULTURED; CHOLESTEROL ESTERS; FATTY ACIDS; FIBROBLASTS; FLAVANONES; FLAVONOIDS; HUMANS; OXIDATION-REDUCTION; SKIN;

EID: 19944428428     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.11.102     Document Type: Article

References (34)

1. M. Dubois-Dalcq, V. Feigenbaum, and P. Aubourg The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder Trends Neurosci. 22 1999 4 12
2. L. Bezman, A.B. Moser, G.V. Raymond, P. Rinaldo, P.A. Watkins, K.D. Smith, N.E. Kass, and H.W. Moser Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening Ann. Neurol. 49 2001 512 517
3. H. Moser, P. Dubey, and A. Fatemi Progress in X-linked adrenoleukodystrophy Curr. Opin. Neurol. 17 2004 263 269
4. Y. Takemoto, Y. Suzuki, N. Shimozawa, A. Tamakoshi, O. Onodera, S. Tsuji, and N. Kondo Epidemiology of X-linked adrenoleukodystrophy in Japan J. Hum. Genet. 47 2002 590 593
5. I. Singh Biochemistry of peroxisomes in health and disease Mol. Cell. Biochem. 167 1997 1 29
6. T. Imanaka, K. Aihara, Y. Suzuki, S. Yokota, and T. Osumi The 70-kDa peroxisomal membrane protein (PMP70), an ATP-binding cassette transporter Cell. Biochem. Biophys. 32 2000 131 138
7. A.R. Tanaka, K. Tanabe, M. Morita, M. Kurisu, Y. Kashiwayama, M. Matsuo, N. Kioka, T. Amachi, T. Imanaka, and K. Ueda ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1) J. Biol. Chem. 277 2002 40142 40147
8. Y. Kashiwayama, M. Morita, K. Kamijo, and T. Imanaka Nucleotide-induced conformational changes of PMP70, an ATP binding cassette transporter on rat liver peroxisomal membranes Biochem. Biophys. Res. Commun. 291 2002 1245 1251
9. H.W. Moser, G.V. Raymond, W. Koehler, P. Sokolowski, F. Hanefeld, G.C. Korenke, A. Green, D.J. Loes, D.H. Hunneman, R.O. Jones, S.E. Lu, G. Uziel, M.L. Giros, and F. Roels Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials Adv. Exp. Med. Biol. 544 2003 369 387
10. P. Aubourg, S. Blanche, I. Jambaque, F. Rocchiccioli, G. Kalifa, C. Naud-Saudreau, M.O. Rolland, M. Debre, J.L. Chaussain, and C. Griscelli Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation N. Engl. J. Med. 322 1990 1860 1866
11. E. Middleton, and C. Kandaswami The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer J.B. Harborne The Flavonoids: Advances in Research Since 1986 1988 Chapman & Hall London 619 645
12. J.B. Harborne The Flavonoids: Advances in Research Since 1986 1988 Chapman & Hall New York
13. A. Imamura, Y. Suzuki, X.Q. Song, T. Fukao, A. Uchiyama, N. Shimozawa, K. Kamijo, T. Hashimoto, T. Orii, and N. Kondo Two novel missense mutations in the ATP-binding domain of the adrenoleukodystrophy gene: immunoblotting and immunocytological study of two patients Clin. Genet. 51 1997 322 325
14. T. Kobayashi, M. Katayama, S. Suzuki, H. Tomoda, I. Goto, and Y. Kuroiwa Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography J. Neurol. 230 1983 209 215
15. Y. Suzuki, N. Shimozawa, S. Yajima, S. Yamaguchi, T. Orii, and T. Hashimoto Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases Biochem. Pharmacol. 41 1991 453 456
16. T. Imanaka, K. Aihara, T. Takano, A. Yamashita, R. Sato, Y. Suzuki, S. Yokota, and T. Osumi Characterization of the 70-kDa peroxisomal membrane protein, an ATP binding cassette transporter J. Biol. Chem. 274 1999 11968 11976
17. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
18. M. Kurisu, M. Morita, Y. Kashiwayama, S. Yokota, H. Hayashi, Y. Sakai, S. Ohkuma, M. Nishimura, and T. Imanaka Existence of catalase-less peroxisomes in Sf21 insect cells Biochem. Biophys. Res. Commun. 306 2003 169 176
19. T. Imanaka, Y. Shiina, T. Takano, T. Hashimoto, and T. Osumi Insertion of the 70-kDa peroxisomal membrane protein into peroxisomal membranes in vivo and in vitro J. Biol. Chem. 271 1996 3706 3713
20. T. Yasutake, T. Yamada, H. Furuya, N. Shinoh, I. Goto, and T. Kobayashi Molecular analysis of X-linked adrenoleukodystrophy patients J. Neurol. Sci. 131 1995 58 64
21. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
22. I. Singh, K. Pahan, and M. Khan Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy FEBS Lett. 426 1998 342 346
23. M.C. McGuinness, J.-F. Lu, H.-P. Zhang, G.-X. Dong, A.K. Heinzer, P.A. Watkins, J. Powers, and K.D. Smith Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy Mol. Cell. Biol. 23 2003 744 753
24. H. Wei, S. Kemp, M.C. McGuinness, A.B. Moser, and K.D. Smith Pharmacological induction of peroxisomes in peroxisome biogenesis disorders Ann. Neurol. 47 2000 286 296
25. S. Kemp, H. Wei, J.F. Lu, L.T. Braiterman, M.C. McGuinness, A.B. Moser, P.A. Watkins, and K.D. Smith Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy Nat. Med. 4 1998 1261 1268
26. J.M. Powers, H.H. Schaumburg, A.B. Johnson, and C.S. Raine A correlative study of the adrenal cortex in adreno-leukodystrophy - evidence for a fatal intoxication with very long chain saturated fatty acids Invest. Cell Pathol. 3 1980 353 376
27. I. Singh, A.E. Moser, H.W. Moser, and Y. Kishimoto Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and aminocytes Pediatr. Res. 18 1984 286 290
28. R. Koike, S. Tsuji, T. Ohno, Y. Suzuki, T. Orii, and T. Miyatake Physiological significance of fatty acid elongation system in adrenoleukodystrophy J. Neurol. Sci. 103 1991 188 194
29. A.K. Heinzer, P.A. Watkins, J.F. Lu, S. Kemp, A.B. Moser, Y.Y. Li, S. Mihalik, J.M. Powers, and K.D. Smith A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy Hum. Mol. Genet. 12 2003 1145 1154
30. M.C. McGuinness, H.-P. Zhang, and K.D. Smith Evaluation of pharmacological induction of fatty acid β-oxidation in X-linked adrenoleukodystrophy Mol. Gen. Metab. 74 2001 256 263
31. A. Petroni, M. Blasevich, and G. Uziel Effects of the testosterone metabolite dihydrotestosterone and 5α-androstan-3α, 17β-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts Life Sci. 73 2003 1567 1575
32. E. Yavin, A. Milunsky, G.R. DeLong, A.H. Nash, and E.H. Kolodny Cholesterol metabolism in cultured fibroblasts in adrenoleukodystrophy Pediatr. Res. 10 1976 540 545
33. A.C. Paladini, M. Marder, H. Viola, C. Wolfman, C. Wasowski, and J.H. Medina Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds J. Pharm. Pharmacol. 51 1999 519 526
34. D. Kavvadias, P. Sand, K.A. Youdim, M.Z. Qaiser, C. Rice-Evans, R. Baur, E. Sigel, W.D. Rausch, P. Riederer, and P. Schreier The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects Br. J. Pharmacol. 142 2004 811 820